148 related articles for article (PubMed ID: 23638052)
1. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury.
Li Q; Zhou X; Shi Y; Li J; Zheng L; Cui L; Zhang J; Wang L; Han Z; Han Y; Fan D
PLoS One; 2013; 8(4):e62363. PubMed ID: 23638052
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver.
Chen Y; Xiang LX; Shao JZ; Pan RL; Wang YX; Dong XJ; Zhang GR
J Cell Mol Med; 2010 Jun; 14(6B):1494-508. PubMed ID: 19780871
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice.
Nasir GA; Mohsin S; Khan M; Shams S; Ali G; Khan SN; Riazuddin S
J Transl Med; 2013 Mar; 11():78. PubMed ID: 23531302
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells as supportive cells for hepatocytes.
Gómez-Aristizábal A; Keating A; Davies JE
Mol Ther; 2009 Sep; 17(9):1504-8. PubMed ID: 19584815
[TBL] [Abstract][Full Text] [Related]
5. Functional 3D Human Liver Bud Assembled from MSC-Derived Multiple Liver Cell Lineages.
Li J; Xing F; Chen F; He L; So KF; Liu Y; Xiao J
Cell Transplant; 2019 May; 28(5):510-521. PubMed ID: 29895168
[TBL] [Abstract][Full Text] [Related]
6. Influential factors for optimizing and strengthening mesenchymal stem cells and hematopoietic stem cells co-culture.
Shirdare M; Amiri F; Samiee MP; Safari A
Mol Biol Rep; 2024 Jan; 51(1):189. PubMed ID: 38270694
[TBL] [Abstract][Full Text] [Related]
7. Bioreactor-based stem cell therapy for liver fibrosis.
Yan M; Yao J; Xie Y; Jiang P; Yan J; Li X
Biofabrication; 2024 Mar; 16(2):. PubMed ID: 38442726
[TBL] [Abstract][Full Text] [Related]
8. Concise review: clinical programs of stem cell therapies for liver and pancreas.
Lanzoni G; Oikawa T; Wang Y; Cui CB; Carpino G; Cardinale V; Gerber D; Gabriel M; Dominguez-Bendala J; Furth ME; Gaudio E; Alvaro D; Inverardi L; Reid LM
Stem Cells; 2013 Oct; 31(10):2047-60. PubMed ID: 23873634
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stromal Cells Facilitate Neutrophil-Trained Immunity by Reprogramming Hematopoietic Stem Cells.
Ng J; Marneth AE; Griffith A; Younger D; Ghanta S; Jiao A; Willis G; Han J; Imani J; Niu B; Keegan JW; Hancock B; Guo F; Shi Y; Perrella MA; Lederer JA
J Innate Immun; 2023; 15(1):765-781. PubMed ID: 37797588
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges.
Yadav P; Singh SK; Rajput S; Allawadhi P; Khurana A; Weiskirchen R; Navik U
Pharmacol Ther; 2024 Jan; 253():108563. PubMed ID: 38013053
[TBL] [Abstract][Full Text] [Related]
11. Efficient delivery of mesenchymal stem/stromal cells to injured liver by surface PEGylation.
Takayama Y; Kusamori K; Katsurada Y; Obana S; Itakura S; Nishikawa M
Stem Cell Res Ther; 2023 Aug; 14(1):216. PubMed ID: 37608303
[TBL] [Abstract][Full Text] [Related]
12. Kupffer cells abrogate homing and repopulation of allogeneic hepatic progenitors in injured liver site.
Abbas N; You K; Getachew A; Wu F; Hussain M; Huang X; Chen Y; Pan T; Li Y
Stem Cell Res Ther; 2024 Feb; 15(1):48. PubMed ID: 38378583
[TBL] [Abstract][Full Text] [Related]
13. Intrasplenic transplantation of bioencapsulated mesenchymal stem cells improves the recovery rates of 90% partial hepatectomized rats.
Liu ZC; Chang TM
Stem Cells Int; 2012; 2012():697094. PubMed ID: 23251190
[TBL] [Abstract][Full Text] [Related]
14. Bispecific Antibody Inhalation Therapy for Redirecting Stem Cells from the Lungs to Repair Heart Injury.
Liu M; Lutz H; Zhu D; Huang K; Li Z; Dinh PC; Gao J; Zhang Y; Cheng K
Adv Sci (Weinh); 2020 Jan; 8(1):2002127. PubMed ID: 33437573
[TBL] [Abstract][Full Text] [Related]
15. Viscoelastic Multiscale Mechanical Indexes for Assessing Liver Fibrosis and Treatment Outcomes.
Chang Z; Zhang L; Hang JT; Liu W; Xu GK
Nano Lett; 2023 Oct; 23(20):9618-9625. PubMed ID: 37793647
[TBL] [Abstract][Full Text] [Related]
16. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.
Liu WH; Song FQ; Ren LN; Guo WQ; Wang T; Feng YX; Tang LJ; Li K
J Cell Mol Med; 2015 Mar; 19(3):511-20. PubMed ID: 25534251
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Regeneration in Cirrhosis.
Jindal A; Jagdish RK; Kumar A
J Clin Exp Hepatol; 2022; 12(2):603-616. PubMed ID: 35535091
[TBL] [Abstract][Full Text] [Related]
18. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases.
Xu SJ; Ye LP; Wang W; Chen YH; Dong J; Mao XL; Li SW
Stem Cells Int; 2021; 2021():5513309. PubMed ID: 34824587
[TBL] [Abstract][Full Text] [Related]
19. Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies.
Wiśniewska J; Sadowska A; Wójtowicz A; Słyszewska M; Szóstek-Mioduchowska A
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685439
[TBL] [Abstract][Full Text] [Related]
20. Platelets Boost Recruitment of CD133
Lehwald N; Duhme C; Pinchuk I; Kirchner J; Wieferich K; Schmelzle M; Jurk K; Windmöller BA; Hübner W; Homey B; Bode J; Kubitz R; Benhidjeb T; Krüger M; Robson SC; Knoefel WT; Kehrel BE; Schulte Am Esch J
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
